Global Cephalosporine API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 304904
  • calendar_today Published On: Jun, 2022
  • file_copy Pages: 156
  • list Chemical and Material
Buy @ $3500

The Cephalosporine API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Cephalosporine API market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Oral accounting for % of the Cephalosporine API global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While First Generation segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Cephalosporine API include Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals, and Hospira, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Cephalosporine API market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

First Generation

Second Generation

Third Generation

Fourth Generation

Market segment by Application can be divided into

Oral

Injection

The key market players for global Cephalosporine API market are listed below:

Union Chempharma

NCPC

Qilu Antibiotics

Lupin Pharmaceuticals

Hospira

Dhanuka Laboratories

Fukang

Dongying Pharmaceutical

Alkem

SALUBRIS

LIVZON

Hetero Drugs

CSPC

TEVA

Orchid Pharma

Taj Pharmaceuticals

Covalent Laboratories

United Laboratories

Aurobindo

Wockhardt

LKPC

HPGC

Huafangpharm

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Cephalosporine API product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Cephalosporine API, with price, sales, revenue and global market share of Cephalosporine API from 2019 to 2022.

Chapter 3, the Cephalosporine API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Cephalosporine API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Cephalosporine API market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Cephalosporine API.

Chapter 13, 14, and 15, to describe Cephalosporine API sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Cephalosporine API Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Cephalosporine API Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 First Generation

1.2.3 Second Generation

1.2.4 Third Generation

1.2.5 Fourth Generation

1.3 Market Analysis by Application

1.3.1 Overview: Global Cephalosporine API Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 Oral

1.3.3 Injection

1.4 Global Cephalosporine API Market Size & Forecast

1.4.1 Global Cephalosporine API Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Cephalosporine API Sales in Volume (2017-2028)

1.4.3 Global Cephalosporine API Price (2017-2028)

1.5 Global Cephalosporine API Production Capacity Analysis

1.5.1 Global Cephalosporine API Total Production Capacity (2017-2028)

1.5.2 Global Cephalosporine API Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Cephalosporine API Market Drivers

1.6.2 Cephalosporine API Market Restraints

1.6.3 Cephalosporine API Trends Analysis

2 Manufacturers Profiles

2.1 Union Chempharma

2.1.1 Union Chempharma Details

2.1.2 Union Chempharma Major Business

2.1.3 Union Chempharma Cephalosporine API Product and Services

2.1.4 Union Chempharma Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 NCPC

2.2.1 NCPC Details

2.2.2 NCPC Major Business

2.2.3 NCPC Cephalosporine API Product and Services

2.2.4 NCPC Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 Qilu Antibiotics

2.3.1 Qilu Antibiotics Details

2.3.2 Qilu Antibiotics Major Business

2.3.3 Qilu Antibiotics Cephalosporine API Product and Services

2.3.4 Qilu Antibiotics Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 Lupin Pharmaceuticals

2.4.1 Lupin Pharmaceuticals Details

2.4.2 Lupin Pharmaceuticals Major Business

2.4.3 Lupin Pharmaceuticals Cephalosporine API Product and Services

2.4.4 Lupin Pharmaceuticals Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5 Hospira

2.5.1 Hospira Details

2.5.2 Hospira Major Business

2.5.3 Hospira Cephalosporine API Product and Services

2.5.4 Hospira Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6 Dhanuka Laboratories

2.6.1 Dhanuka Laboratories Details

2.6.2 Dhanuka Laboratories Major Business

2.6.3 Dhanuka Laboratories Cephalosporine API Product and Services

2.6.4 Dhanuka Laboratories Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7 Fukang

2.7.1 Fukang Details

2.7.2 Fukang Major Business

2.7.3 Fukang Cephalosporine API Product and Services

2.7.4 Fukang Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8 Dongying Pharmaceutical

2.8.1 Dongying Pharmaceutical Details

2.8.2 Dongying Pharmaceutical Major Business

2.8.3 Dongying Pharmaceutical Cephalosporine API Product and Services

2.8.4 Dongying Pharmaceutical Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9 Alkem

2.9.1 Alkem Details

2.9.2 Alkem Major Business

2.9.3 Alkem Cephalosporine API Product and Services

2.9.4 Alkem Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10 SALUBRIS

2.10.1 SALUBRIS Details

2.10.2 SALUBRIS Major Business

2.10.3 SALUBRIS Cephalosporine API Product and Services

2.10.4 SALUBRIS Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11 LIVZON

2.11.1 LIVZON Details

2.11.2 LIVZON Major Business

2.11.3 LIVZON Cephalosporine API Product and Services

2.11.4 LIVZON Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12 Hetero Drugs

2.12.1 Hetero Drugs Details

2.12.2 Hetero Drugs Major Business

2.12.3 Hetero Drugs Cephalosporine API Product and Services

2.12.4 Hetero Drugs Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13 CSPC

2.13.1 CSPC Details

2.13.2 CSPC Major Business

2.13.3 CSPC Cephalosporine API Product and Services

2.13.4 CSPC Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14 TEVA

2.14.1 TEVA Details

2.14.2 TEVA Major Business

2.14.3 TEVA Cephalosporine API Product and Services

2.14.4 TEVA Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15 Orchid Pharma

2.15.1 Orchid Pharma Details

2.15.2 Orchid Pharma Major Business

2.15.3 Orchid Pharma Cephalosporine API Product and Services

2.15.4 Orchid Pharma Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16 Taj Pharmaceuticals

2.16.1 Taj Pharmaceuticals Details

2.16.2 Taj Pharmaceuticals Major Business

2.16.3 Taj Pharmaceuticals Cephalosporine API Product and Services

2.16.4 Taj Pharmaceuticals Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17 Covalent Laboratories

2.17.1 Covalent Laboratories Details

2.17.2 Covalent Laboratories Major Business

2.17.3 Covalent Laboratories Cephalosporine API Product and Services

2.17.4 Covalent Laboratories Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18 United Laboratories

2.18.1 United Laboratories Details

2.18.2 United Laboratories Major Business

2.18.3 United Laboratories Cephalosporine API Product and Services

2.18.4 United Laboratories Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19 Aurobindo

2.19.1 Aurobindo Details

2.19.2 Aurobindo Major Business

2.19.3 Aurobindo Cephalosporine API Product and Services

2.19.4 Aurobindo Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.20 Wockhardt

2.20.1 Wockhardt Details

2.20.2 Wockhardt Major Business

2.20.3 Wockhardt Cephalosporine API Product and Services

2.20.4 Wockhardt Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.21 LKPC

2.21.1 LKPC Details

2.21.2 LKPC Major Business

2.21.3 LKPC Cephalosporine API Product and Services

2.21.4 LKPC Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.22 HPGC

2.22.1 HPGC Details

2.22.2 HPGC Major Business

2.22.3 HPGC Cephalosporine API Product and Services

2.22.4 HPGC Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.23 Huafangpharm

2.23.1 Huafangpharm Details

2.23.2 Huafangpharm Major Business

2.23.3 Huafangpharm Cephalosporine API Product and Services

2.23.4 Huafangpharm Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Cephalosporine API Breakdown Data by Manufacturer

3.1 Global Cephalosporine API Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Cephalosporine API Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Cephalosporine API

3.4 Market Concentration Rate

3.4.1 Top 3 Cephalosporine API Manufacturer Market Share in 2021

3.4.2 Top 6 Cephalosporine API Manufacturer Market Share in 2021

3.5 Global Cephalosporine API Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Cephalosporine API Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Cephalosporine API Market Size by Region

4.1.1 Global Cephalosporine API Sales in Volume by Region (2017-2028)

4.1.2 Global Cephalosporine API Revenue by Region (2017-2028)

4.2 North America Cephalosporine API Revenue (2017-2028)

4.3 Europe Cephalosporine API Revenue (2017-2028)

4.4 Asia-Pacific Cephalosporine API Revenue (2017-2028)

4.5 South America Cephalosporine API Revenue (2017-2028)

4.6 Middle East and Africa Cephalosporine API Revenue (2017-2028)

5 Market Segment by Type

5.1 Global Cephalosporine API Sales in Volume by Type (2017-2028)

5.2 Global Cephalosporine API Revenue by Type (2017-2028)

5.3 Global Cephalosporine API Price by Type (2017-2028)

6 Market Segment by Application

6.1 Global Cephalosporine API Sales in Volume by Application (2017-2028)

6.2 Global Cephalosporine API Revenue by Application (2017-2028)

6.3 Global Cephalosporine API Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7.1 North America Cephalosporine API Sales by Type (2017-2028)

7.2 North America Cephalosporine API Sales by Application (2017-2028)

7.3 North America Cephalosporine API Market Size by Country

7.3.1 North America Cephalosporine API Sales in Volume by Country (2017-2028)

7.3.2 North America Cephalosporine API Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Cephalosporine API Sales by Type (2017-2028)

8.2 Europe Cephalosporine API Sales by Application (2017-2028)

8.3 Europe Cephalosporine API Market Size by Country

8.3.1 Europe Cephalosporine API Sales in Volume by Country (2017-2028)

8.3.2 Europe Cephalosporine API Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Cephalosporine API Sales by Type (2017-2028)

9.2 Asia-Pacific Cephalosporine API Sales by Application (2017-2028)

9.3 Asia-Pacific Cephalosporine API Market Size by Region

9.3.1 Asia-Pacific Cephalosporine API Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Cephalosporine API Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10.1 South America Cephalosporine API Sales by Type (2017-2028)

10.2 South America Cephalosporine API Sales by Application (2017-2028)

10.3 South America Cephalosporine API Market Size by Country

10.3.1 South America Cephalosporine API Sales in Volume by Country (2017-2028)

10.3.2 South America Cephalosporine API Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Cephalosporine API Sales by Type (2017-2028)

11.2 Middle East & Africa Cephalosporine API Sales by Application (2017-2028)

11.3 Middle East & Africa Cephalosporine API Market Size by Country

11.3.1 Middle East & Africa Cephalosporine API Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Cephalosporine API Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12.1 Raw Material of Cephalosporine API and Key Manufacturers

12.2 Manufacturing Costs Percentage of Cephalosporine API

12.3 Cephalosporine API Production Process

12.4 Cephalosporine API Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Cephalosporine API Typical Distributors

13.3 Cephalosporine API Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Cephalosporine API Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Cephalosporine API Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. Union Chempharma Basic Information, Manufacturing Base and Competitors

Table 4. Union Chempharma Major Business

Table 5. Union Chempharma Cephalosporine API Product and Services

Table 6. Union Chempharma Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. NCPC Basic Information, Manufacturing Base and Competitors

Table 8. NCPC Major Business

Table 9. NCPC Cephalosporine API Product and Services

Table 10. NCPC Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. Qilu Antibiotics Basic Information, Manufacturing Base and Competitors

Table 12. Qilu Antibiotics Major Business

Table 13. Qilu Antibiotics Cephalosporine API Product and Services

Table 14. Qilu Antibiotics Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. Lupin Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 16. Lupin Pharmaceuticals Major Business

Table 17. Lupin Pharmaceuticals Cephalosporine API Product and Services

Table 18. Lupin Pharmaceuticals Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. Hospira Basic Information, Manufacturing Base and Competitors

Table 20. Hospira Major Business

Table 21. Hospira Cephalosporine API Product and Services

Table 22. Hospira Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 23. Dhanuka Laboratories Basic Information, Manufacturing Base and Competitors

Table 24. Dhanuka Laboratories Major Business

Table 25. Dhanuka Laboratories Cephalosporine API Product and Services

Table 26. Dhanuka Laboratories Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 27. Fukang Basic Information, Manufacturing Base and Competitors

Table 28. Fukang Major Business

Table 29. Fukang Cephalosporine API Product and Services

Table 30. Fukang Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 31. Dongying Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 32. Dongying Pharmaceutical Major Business

Table 33. Dongying Pharmaceutical Cephalosporine API Product and Services

Table 34. Dongying Pharmaceutical Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 35. Alkem Basic Information, Manufacturing Base and Competitors

Table 36. Alkem Major Business

Table 37. Alkem Cephalosporine API Product and Services

Table 38. Alkem Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 39. SALUBRIS Basic Information, Manufacturing Base and Competitors

Table 40. SALUBRIS Major Business

Table 41. SALUBRIS Cephalosporine API Product and Services

Table 42. SALUBRIS Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 43. LIVZON Basic Information, Manufacturing Base and Competitors

Table 44. LIVZON Major Business

Table 45. LIVZON Cephalosporine API Product and Services

Table 46. LIVZON Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 47. Hetero Drugs Basic Information, Manufacturing Base and Competitors

Table 48. Hetero Drugs Major Business

Table 49. Hetero Drugs Cephalosporine API Product and Services

Table 50. Hetero Drugs Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 51. CSPC Basic Information, Manufacturing Base and Competitors

Table 52. CSPC Major Business

Table 53. CSPC Cephalosporine API Product and Services

Table 54. CSPC Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 55. TEVA Basic Information, Manufacturing Base and Competitors

Table 56. TEVA Major Business

Table 57. TEVA Cephalosporine API Product and Services

Table 58. TEVA Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 59. Orchid Pharma Basic Information, Manufacturing Base and Competitors

Table 60. Orchid Pharma Major Business

Table 61. Orchid Pharma Cephalosporine API Product and Services

Table 62. Orchid Pharma Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 63. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 64. Taj Pharmaceuticals Major Business

Table 65. Taj Pharmaceuticals Cephalosporine API Product and Services

Table 66. Taj Pharmaceuticals Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 67. Covalent Laboratories Basic Information, Manufacturing Base and Competitors

Table 68. Covalent Laboratories Major Business

Table 69. Covalent Laboratories Cephalosporine API Product and Services

Table 70. Covalent Laboratories Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 71. United Laboratories Basic Information, Manufacturing Base and Competitors

Table 72. United Laboratories Major Business

Table 73. United Laboratories Cephalosporine API Product and Services

Table 74. United Laboratories Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 75. Aurobindo Basic Information, Manufacturing Base and Competitors

Table 76. Aurobindo Major Business

Table 77. Aurobindo Cephalosporine API Product and Services

Table 78. Aurobindo Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 79. Wockhardt Basic Information, Manufacturing Base and Competitors

Table 80. Wockhardt Major Business

Table 81. Wockhardt Cephalosporine API Product and Services

Table 82. Wockhardt Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 83. LKPC Basic Information, Manufacturing Base and Competitors

Table 84. LKPC Major Business

Table 85. LKPC Cephalosporine API Product and Services

Table 86. LKPC Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 87. HPGC Basic Information, Manufacturing Base and Competitors

Table 88. HPGC Major Business

Table 89. HPGC Cephalosporine API Product and Services

Table 90. HPGC Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 91. Huafangpharm Basic Information, Manufacturing Base and Competitors

Table 92. Huafangpharm Major Business

Table 93. Huafangpharm Cephalosporine API Product and Services

Table 94. Huafangpharm Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 95. Global Cephalosporine API Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kiloton)

Table 96. Global Cephalosporine API Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 97. Market Position of Manufacturers in Cephalosporine API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 98. Global Cephalosporine API Production Capacity by Company, (Kiloton): 2020 VS 2021

Table 99. Head Office and Cephalosporine API Production Site of Key Manufacturer

Table 100. Cephalosporine API New Entrant and Capacity Expansion Plans

Table 101. Cephalosporine API Mergers & Acquisitions in the Past Five Years

Table 102. Global Cephalosporine API Sales by Region (2017-2022) & (Kiloton)

Table 103. Global Cephalosporine API Sales by Region (2023-2028) & (Kiloton)

Table 104. Global Cephalosporine API Revenue by Region (2017-2022) & (USD Million)

Table 105. Global Cephalosporine API Revenue by Region (2023-2028) & (USD Million)

Table 106. Global Cephalosporine API Sales by Type (2017-2022) & (Kiloton)

Table 107. Global Cephalosporine API Sales by Type (2023-2028) & (Kiloton)

Table 108. Global Cephalosporine API Revenue by Type (2017-2022) & (USD Million)

Table 109. Global Cephalosporine API Revenue by Type (2023-2028) & (USD Million)

Table 110. Global Cephalosporine API Price by Type (2017-2022) & (US$/Ton)

Table 111. Global Cephalosporine API Price by Type (2023-2028) & (US$/Ton)

Table 112. Global Cephalosporine API Sales by Application (2017-2022) & (Kiloton)

Table 113. Global Cephalosporine API Sales by Application (2023-2028) & (Kiloton)

Table 114. Global Cephalosporine API Revenue by Application (2017-2022) & (USD Million)

Table 115. Global Cephalosporine API Revenue by Application (2023-2028) & (USD Million)

Table 116. Global Cephalosporine API Price by Application (2017-2022) & (US$/Ton)

Table 117. Global Cephalosporine API Price by Application (2023-2028) & (US$/Ton)

Table 118. North America Cephalosporine API Sales by Country (2017-2022) & (Kiloton)

Table 119. North America Cephalosporine API Sales by Country (2023-2028) & (Kiloton)

Table 120. North America Cephalosporine API Revenue by Country (2017-2022) & (USD Million)

Table 121. North America Cephalosporine API Revenue by Country (2023-2028) & (USD Million)

Table 122. North America Cephalosporine API Sales by Type (2017-2022) & (Kiloton)

Table 123. North America Cephalosporine API Sales by Type (2023-2028) & (Kiloton)

Table 124. North America Cephalosporine API Sales by Application (2017-2022) & (Kiloton)

Table 125. North America Cephalosporine API Sales by Application (2023-2028) & (Kiloton)

Table 126. Europe Cephalosporine API Sales by Country (2017-2022) & (Kiloton)

Table 127. Europe Cephalosporine API Sales by Country (2023-2028) & (Kiloton)

Table 128. Europe Cephalosporine API Revenue by Country (2017-2022) & (USD Million)

Table 129. Europe Cephalosporine API Revenue by Country (2023-2028) & (USD Million)

Table 130. Europe Cephalosporine API Sales by Type (2017-2022) & (Kiloton)

Table 131. Europe Cephalosporine API Sales by Type (2023-2028) & (Kiloton)

Table 132. Europe Cephalosporine API Sales by Application (2017-2022) & (Kiloton)

Table 133. Europe Cephalosporine API Sales by Application (2023-2028) & (Kiloton)

Table 134. Asia-Pacific Cephalosporine API Sales by Region (2017-2022) & (Kiloton)

Table 135. Asia-Pacific Cephalosporine API Sales by Region (2023-2028) & (Kiloton)

Table 136. Asia-Pacific Cephalosporine API Revenue by Region (2017-2022) & (USD Million)

Table 137. Asia-Pacific Cephalosporine API Revenue by Region (2023-2028) & (USD Million)

Table 138. Asia-Pacific Cephalosporine API Sales by Type (2017-2022) & (Kiloton)

Table 139. Asia-Pacific Cephalosporine API Sales by Type (2023-2028) & (Kiloton)

Table 140. Asia-Pacific Cephalosporine API Sales by Application (2017-2022) & (Kiloton)

Table 141. Asia-Pacific Cephalosporine API Sales by Application (2023-2028) & (Kiloton)

Table 142. South America Cephalosporine API Sales by Country (2017-2022) & (Kiloton)

Table 143. South America Cephalosporine API Sales by Country (2023-2028) & (Kiloton)

Table 144. South America Cephalosporine API Revenue by Country (2017-2022) & (USD Million)

Table 145. South America Cephalosporine API Revenue by Country (2023-2028) & (USD Million)

Table 146. South America Cephalosporine API Sales by Type (2017-2022) & (Kiloton)

Table 147. South America Cephalosporine API Sales by Type (2023-2028) & (Kiloton)

Table 148. South America Cephalosporine API Sales by Application (2017-2022) & (Kiloton)

Table 149. South America Cephalosporine API Sales by Application (2023-2028) & (Kiloton)

Table 150. Middle East & Africa Cephalosporine API Sales by Region (2017-2022) & (Kiloton)

Table 151. Middle East & Africa Cephalosporine API Sales by Region (2023-2028) & (Kiloton)

Table 152. Middle East & Africa Cephalosporine API Revenue by Region (2017-2022) & (USD Million)

Table 153. Middle East & Africa Cephalosporine API Revenue by Region (2023-2028) & (USD Million)

Table 154. Middle East & Africa Cephalosporine API Sales by Type (2017-2022) & (Kiloton)

Table 155. Middle East & Africa Cephalosporine API Sales by Type (2023-2028) & (Kiloton)

Table 156. Middle East & Africa Cephalosporine API Sales by Application (2017-2022) & (Kiloton)

Table 157. Middle East & Africa Cephalosporine API Sales by Application (2023-2028) & (Kiloton)

Table 158. Cephalosporine API Raw Material

Table 159. Key Manufacturers of Cephalosporine API Raw Materials

Table 160. Direct Channel Pros & Cons

Table 161. Indirect Channel Pros & Cons

Table 162. Cephalosporine API Typical Distributors

Table 163. Cephalosporine API Typical Customers

List of Figures

Figure 1. Cephalosporine API Picture

Figure 2. Global Cephalosporine API Revenue Market Share by Type in 2021

Figure 3. First Generation

Figure 4. Second Generation

Figure 5. Third Generation

Figure 6. Fourth Generation

Figure 7. Global Cephalosporine API Revenue Market Share by Application in 2021

Figure 8. Oral

Figure 9. Injection

Figure 10. Global Cephalosporine API Revenue, (USD Million) & (Kiloton): 2017 & 2021 & 2028

Figure 11. Global Cephalosporine API Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Cephalosporine API Sales (2017-2028) & (Kiloton)

Figure 13. Global Cephalosporine API Price (2017-2028) & (US$/Ton)

Figure 14. Global Cephalosporine API Production Capacity (2017-2028) & (Kiloton)

Figure 15. Global Cephalosporine API Production Capacity by Geographic Region: 2022 VS 2028

Figure 16. Cephalosporine API Market Drivers

Figure 17. Cephalosporine API Market Restraints

Figure 18. Cephalosporine API Market Trends

Figure 19. Global Cephalosporine API Sales Market Share by Manufacturer in 2021

Figure 20. Global Cephalosporine API Revenue Market Share by Manufacturer in 2021

Figure 21. Cephalosporine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 22. Top 3 Cephalosporine API Manufacturer (Revenue) Market Share in 2021

Figure 23. Top 6 Cephalosporine API Manufacturer (Revenue) Market Share in 2021

Figure 24. Global Cephalosporine API Sales Market Share by Region (2017-2028)

Figure 25. Global Cephalosporine API Revenue Market Share by Region (2017-2028)

Figure 26. North America Cephalosporine API Revenue (2017-2028) & (USD Million)

Figure 27. Europe Cephalosporine API Revenue (2017-2028) & (USD Million)

Figure 28. Asia-Pacific Cephalosporine API Revenue (2017-2028) & (USD Million)

Figure 29. South America Cephalosporine API Revenue (2017-2028) & (USD Million)

Figure 30. Middle East & Africa Cephalosporine API Revenue (2017-2028) & (USD Million)

Figure 31. Global Cephalosporine API Sales Market Share by Type (2017-2028)

Figure 32. Global Cephalosporine API Revenue Market Share by Type (2017-2028)

Figure 33. Global Cephalosporine API Price by Type (2017-2028) & (US$/Ton)

Figure 34. Global Cephalosporine API Sales Market Share by Application (2017-2028)

Figure 35. Global Cephalosporine API Revenue Market Share by Application (2017-2028)

Figure 36. Global Cephalosporine API Price by Application (2017-2028) & (US$/Ton)

Figure 37. North America Cephalosporine API Sales Market Share by Type (2017-2028)

Figure 38. North America Cephalosporine API Sales Market Share by Application (2017-2028)

Figure 39. North America Cephalosporine API Sales Market Share by Country (2017-2028)

Figure 40. North America Cephalosporine API Revenue Market Share by Country (2017-2028)

Figure 41. United States Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Canada Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Mexico Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Europe Cephalosporine API Sales Market Share by Type (2017-2028)

Figure 45. Europe Cephalosporine API Sales Market Share by Application (2017-2028)

Figure 46. Europe Cephalosporine API Sales Market Share by Country (2017-2028)

Figure 47. Europe Cephalosporine API Revenue Market Share by Country (2017-2028)

Figure 48. Germany Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. France Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. United Kingdom Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Russia Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Italy Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Asia-Pacific Cephalosporine API Sales Market Share by Region (2017-2028)

Figure 54. Asia-Pacific Cephalosporine API Sales Market Share by Application (2017-2028)

Figure 55. Asia-Pacific Cephalosporine API Sales Market Share by Region (2017-2028)

Figure 56. Asia-Pacific Cephalosporine API Revenue Market Share by Region (2017-2028)

Figure 57. China Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Japan Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Korea Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. India Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Southeast Asia Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Australia Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. South America Cephalosporine API Sales Market Share by Type (2017-2028)

Figure 64. South America Cephalosporine API Sales Market Share by Application (2017-2028)

Figure 65. South America Cephalosporine API Sales Market Share by Country (2017-2028)

Figure 66. South America Cephalosporine API Revenue Market Share by Country (2017-2028)

Figure 67. Brazil Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Argentina Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Middle East & Africa Cephalosporine API Sales Market Share by Type (2017-2028)

Figure 70. Middle East & Africa Cephalosporine API Sales Market Share by Application (2017-2028)

Figure 71. Middle East & Africa Cephalosporine API Sales Market Share by Region (2017-2028)

Figure 72. Middle East & Africa Cephalosporine API Revenue Market Share by Region (2017-2028)

Figure 73. Turkey Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Egypt Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. South Africa Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Manufacturing Cost Structure Analysis of Cephalosporine API in 2021

Figure 78. Manufacturing Process Analysis of Cephalosporine API

Figure 79. Cephalosporine API Industrial Chain

Figure 80. Sales Channel: Direct Channel vs Indirect Channel

Figure 81. Methodology

Figure 82. Research Process and Data Source